Abstract

Retrospective analysis of Hepatitis B serology profiles of a cohort of Hepatitis B Surface antigen positive patients, Sri Lanka Wirasinghe K1 , Abeynayake JI2 , Perera PADMP 1 , Galagoda G2, Nanayakkara SSJ2, Pradeepa SK2 2 Department of Virology, Medical Research Institute, Colombo 08, Abstract Introduction: Currently more than 350 million people are estimated to be chronically infected with Hepatitis B (HBV). The prevalence of HBV in Sri Lanka is estimated to vary between 0.1‐2.5 %. A detailed descriptive statistical analysis has not yet been performed on the available HBV serology profiles in Sri Lanka. Objective: To describe the serology profiles of Hepatitis B surface antigen positive (HBsAg+) patients tested at the medical research institute of Sri Lanka during 2007-2017 Method: A sample of 517 test reports of patients with positive HBsAg was extracted during the period from 2007 to 2017 for analysis. The serology profiling had been done using ELISA technique available at the time of testing. The data collected for each patient consisted of available data on the MRI request form which included age and gender. Results: The mean age of the sample was 36 years (Mdn=36, 95% CI=36‐38 years) and 5% of them were 20 years was 72%, 22% and 20% respectively. There was a significant difference in infectivity (p Conclusions: More than1/5 of HBV infected is of high infectivity. HBeAg positivity appears to be higher in the age group

Highlights

  • More than 350 million people are estimated to be chronically infected with Hepatitis B (HBV)

  • More than1/5 of HBV infected is of high infectivity

  • Hepatitis B e Antigen (HBeAg) positivity appears to be higher in the age group

Read more

Summary

Introduction

More than 350 million people are estimated to be chronically infected with Hepatitis B (HBV). The prevalence of HBV in Sri Lanka is estimated to vary between 0.1‐2.5 percent. More than 350 million people are estimated to be chronically infected with Hepatitis B (HBV).(1) Annual deaths due to HBV are around 780,000. (2) Exact prevalence of HBV infection in SL is unknown.It is estimated to vary between 0.1‐2.5 percent. HBV infection results in a spectrum of liver diseases ranging from acute hepatitis to chronic liver diseases.(3) With increasing age, the risk of chronicity decreases. There for prevention of infections in younger age groups is important.(4). HBV profile inferred natural history and infectivity patterns among different age groups will help health care prevention measures against HBV. Hepatitis B e Antigen (HBeAg) testing is a qualitative marker of HBV replication, showing high infectivity and identifies individuals with a high risk of developing liver cancer.(5) Hepatitis B core Antibody (HB IgM and HB IgG) testing enables categorization into recent or chronic infection

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call